$58.75 -0.86 (%) Bristol-Myers Squibb Co - NYSE

Sep. 3, 2015 | 04:00 PM

Partner Headlines

  1. Bristol-Myers Squibb to Host Investor Teleconference to Discuss World Conference on Lung Cancer (WCLC) Highlights

    Benzinga | Sep. 2, 2015 | 16:16PM EST
  2. U.S. Food and Drug Administration Accepts for Priority Review the Biologics License Application for Empliciti (elotuzumab) for the Treatment of Multiple Myeloma in Patients Who Have Received One or More Prior Therapies

    Benzinga | Sep. 1, 2015 | 07:30AM EST
  3. Benzinga's M&A Chatter for Thursday August 27, 2015

    Benzinga | Aug. 27, 2015 | 19:15PM EST
  4. Allied-Bristol Life Sciences Licenses Platform Technology and Lead Molecules from Yale University

    Benzinga | Aug. 27, 2015 | 04:31AM EST
  5. Weekly Insider Sells Highlight: IMS, NOW, BMY, EA

    GuruFocus | Aug. 11, 2015 | 11:33AM EST
  6. uniQure Receives Additional $53M from Bristol-Myers Squibb for Target Selection Payment and Additional Equity Investment

    Benzinga | Aug. 10, 2015 | 05:03AM EST
  7. Gilead Q2 Earnings Soar As HCV Shines, HIV Rebounds

    IBD | Jul. 28, 2015 | 16:34PM EST
  8. Pfizer, Merck Beat Q2 Views; Sanofi Makes PD-1 Deal

    IBD | Jul. 28, 2015 | 13:03PM EST
  9. Biogen's Big-Volume Plunge Marks End Of 5-Year Run

    IBD | Jul. 24, 2015 | 13:26PM EST
  10. Valeant Posts Princely Gains

    IBD | Jul. 23, 2015 | 18:55PM EST
  11. Bristol-Myers Q2 profit jumps

    IBD | Jul. 23, 2015 | 18:48PM EST
  12. 3 Big-Cap Drugmakers Who Beat Q2 Earnings Estimates

    IBD | Jul. 23, 2015 | 17:50PM EST
  13. Shire Lifts 2015 Guidance On Strong Drug Pipeline

    IBD | Jul. 23, 2015 | 14:42PM EST
  14. Lilly, Bristol-Myers Beat Q2 Views, Lift Guidance

    IBD | Jul. 23, 2015 | 10:58AM EST
  15. Valeant Earnings Soar On M&A, Organic Sales Growth

    IBD | Jul. 23, 2015 | 09:37AM EST
  16. Bristol-Myers Squibb Posts Upbeat Q2 Results, Lifts Profit Forecast

    Benzinga | Jul. 23, 2015 | 09:32AM EST
  17. Stock Futures Up, But Volatile; SanDisk, Cirrus, Fortinet Soar

    IBD | Jul. 23, 2015 | 09:17AM EST
  18. US Stock Futures Rise Ahead Of General Motors, McDonald's Earnings

    Benzinga | Jul. 23, 2015 | 06:55AM EST
  19. European Medicines Agency Validates Two Parallel Type II Variation Applications to Extend the Opdivo (nivolumab) Indication in Europe

    Benzinga | Jul. 23, 2015 | 06:33AM EST
  20. Bristol Myers Announces EMA Validates Two Parallel Type II Variation Applications to Extend Opdivo Indication in Europe

    Benzinga | Jul. 23, 2015 | 06:33AM EST
  21. Earnings Scheduled For July 23, 2015

    Benzinga | Jul. 23, 2015 | 04:46AM EST
  22. Second-Generation Investigational HIV-1 Maturation Inhibitor Demonstrates Positive New Phase IIa Results, Supporting Continued Development

    Benzinga | Jul. 21, 2015 | 14:00PM EST
  23. Ethical-Drug Firms Horizon Pharma, Bristol-Myers Rally

    IBD | Jul. 20, 2015 | 18:50PM EST
  24. Bristol-Myers: kidney drug win

    IBD | Jul. 20, 2015 | 18:41PM EST
  25. Bristol-Myers Announces European Commission Has Approved Nivolumab BMS in Europe

    Benzinga | Jul. 20, 2015 | 12:09PM EST
  26. Bristol-Myers, Exelixis Drugs Score Vs. Kidney Cancer

    IBD | Jul. 20, 2015 | 10:50AM EST
  27. 6 Big-Cap Drugmakers Reporting Earnings Next Week

    IBD | Jul. 18, 2015 | 08:02AM EST
  28. Bristol-Myers' HIV-1 Drug Approved In Europe

    Benzinga | Jul. 16, 2015 | 12:07PM EST
  29. What Will Gilead Buy Next? 4 Possible Targets

    IBD | Jul. 15, 2015 | 16:44PM EST
  30. CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton

    Benzinga | Jul. 10, 2015 | 06:52AM EST
  31. Fast Money Picks For July 7

    Benzinga | Jul. 7, 2015 | 06:47AM EST
  32. Biogen, AGTC Link Up To Develop Gene Therapy

    IBD | Jul. 2, 2015 | 11:28AM EST
  33. Can Hepatitis B Be A Blockbuster Bug?

    IBD | Jul. 1, 2015 | 08:02AM EST
  34. Amgen Among 3 Medical Giants With Healthy Payouts

    IBD | Jun. 30, 2015 | 18:33PM EST
  35. Will Bill Ackman Go After Express Scripts Next?

    GuruFocus | Jun. 30, 2015 | 14:55PM EST
  36. Fast Money Picks For June 30

    Benzinga | Jun. 30, 2015 | 07:23AM EST
  37. Aetna Said Close To Humana Deal; Kroger Ups Dividend

    IBD | Jun. 25, 2015 | 15:06PM EST
  38. Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story

    GuruFocus | Jun. 22, 2015 | 18:34PM EST
  39. Benzinga's Top Initiations

    Benzinga | Jun. 17, 2015 | 09:29AM EST
  40. Piper Jaffray Initiates Bristol-Myers Squibb With Underperform

    Benzinga | Jun. 17, 2015 | 08:09AM EST
  41. Axovant Sciences Sets 20-Year Record For Biotech IPOs

    IBD | Jun. 11, 2015 | 16:58PM EST
  42. What We Don't Know About Antibiotics Could Kill Us

    FoxBusiness | Jun. 11, 2015 | 05:00AM EST
  43. 2 M&A Rumors Moving The Market

    Benzinga | Jun. 4, 2015 | 15:29PM EST
  44. ImmunoGen Surprises, PD-1 Drugs Under Scrutiny At ASCO

    IBD | Jun. 1, 2015 | 17:48PM EST
  45. Stocks Protect Solid Gains; Bullish Setup For Zebra Technologies

    IBD | Jun. 1, 2015 | 15:10PM EST
  46. Stocks Eke Out Narrow Gains; eBay Breakout Gains Traction

    IBD | Jun. 1, 2015 | 13:26PM EST
  47. Options Outlook: Market Switches From 'Headline' To 'Sentiment' Mode

    Benzinga | Jun. 1, 2015 | 12:59PM EST
  48. 4 Stocks Rising On ASCO Cancer Drug News

    IBD | Jun. 1, 2015 | 12:34PM EST
  49. Stocks Step Out To Mixed Start; Bristol Myers Rises, Wynn Fades

    IBD | Jun. 1, 2015 | 10:37AM EST
  50. Bristol Dives On Cancer Drug

    IBD | May. 29, 2015 | 18:43PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!